INmune Bio(INMB) - 2025 Q3 - Quarterly Results

Exhibit 99.1 INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update Company to Host Conference Call Today, October 30, at 4:30pm ET BOCA RATON, Fla., Oct. 30, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical- stage inflammation and immunology company focused on developing treatments that harness the patient's innate immune system to fight disease, today announces its financial results for the quarter ended September 30, 2025 and provides a busine ...